S

Stanford Health Care | Stanford Neuroscience Health Center (SNHC)

Research site
(Unclaimed)
Location
213 Quarry Road Room 2726A, Palo Alto, California, United States of America
Site insights

Top conditions

Retinitis (2 trials)

Retinitis Pigmentosa (2 trials)

Mycoses (1 trial)

Invasive Fungal Infections (1 trial)

Ovarian Cancer (1 trial)

Top treatments

Platinum
Voriconazole
Isavuconazonium sulfate
Posaconazole
JNJ-81201887
thiazide

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

3 of 12
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

The purpose of this study is to evaluate change in geographic atrophy (GA) lesion growth of eyes treated with JNJ-81201887 compared to sham control.

Enrolling
Geographic Atrophy
Drug: Triamcinolone
Other: Sham Procedure

A clinical trial of AAV5-hRKp.RPGR vector for participants with X-linked retinitis pigmentosa (XLRP)

Active, not recruiting
X-Linked Retinitis Pigmentosa
Biological: Genetic: AAV5-hRKp.RPGR Intermediate Dose
Biological: Genetic: AAV5-hRKp.RPGR Low Dose

A clinical trial of AAV5-RPGR vector for participants with X-linked retinitis pigmentosa (XLRP)

Active, not recruiting
X-Linked Retinitis Pigmentosa
Biological: Genetic: AAV5-hRKp.RPGR

Trial sponsors

Stanford University logo

Stanford University (4 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems